Pfizer was engaged in search of drugs for cancer through IBM Watson

In December, 2016 the IBM IT corporation and pharmaceutical giant Pfizer agreed about cooperation in the field of creation of technologies and drugs for fight against cancer. The Watson supercomputer will become a basis for joint solutions.

Pfizer will use Watson to accelerate process of the analysis and  check of hypotheses which are based on the basis of  "Big Data from separate sources". More than 30  million laboratory and  statistic reports  and also medical literature concern the last. Watson will be able to integrate this extensive information array with  results of own researches of Pfizer.

Pfizer was engaged in search of drugs for cancer through IBM Watson

The company will use a cloud solution of Watson for Drug Discovery which helps researchers to find the new ideas for medicines and the indication for their application. The average scientist reads about 200-300 scientific works a year, and the Watson for Drug Discovery platform is capable to process 25 million brief summaries on medical sciences from Medline base, it is more than 1 million full articles from magazines, the description of 4 million patents and many other things.

Search of drugs and  development of approaches to  treatment  in the field of immunooncology  is a huge task  — the head of the global direction of development and  researches of Pfizer Mikael Dolsten (Mikael Dolsten) says.  — I read hundreds of articles for the last months, but I  cannot read millions as Watson.

According to him, without artificial intelligence which allocates Watson search of new drugs and  creation of hypotheses is similar to attempts to find three identical trees in the forest.

The vice president of IBM Watson Health Lauren O'Donnell notes that researchers and doctors need the special tools helping to be guided effectively in  those opportunities and  tasks which appeared as a result of fast development of technologies.^[1]

Notes